Following surgery, doctors advised the model to undergo a mastectomy with radiation, chemotherapy and a breast reconstruction.
Vous n'êtes pas connecté
The decision to treat patients with stage II colon cancer with adjuvant chemotherapy remains controversial. Therefore, there is an urgent need to identify reliable prognostic biomarkers that may be used to identify which patients would benefit from chemotherapy following surgery. In a ground-breaking study investigators assess the biomarker potential of RNAs in stage II colon cancer. Their [...]
Following surgery, doctors advised the model to undergo a mastectomy with radiation, chemotherapy and a breast reconstruction.
Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
WEDNESDAY, Sept. 4, 2024 -- Higher suicide deaths are seen among cancer patients who do not undergo recommended surgery, according to a research...
Illumina's cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding...
Can a blood test predict cancer risk in people with type 2 diabetes? A study reveals that measuring IL-6 levels may help identify high-risk...
FRIDAY, Sept. 6, 2024 -- Machine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study...
Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.